e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Novel cellular mechanisms in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Haemophilus influenzae
(NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue
K. Rohmann, J. Rupp, T. Goldmann, P. Zabel, K. Dalhoff, D. Droemann (Luebeck, Germany)
Source:
Annual Congress 2010 - Novel cellular mechanisms in lung disease
Session:
Novel cellular mechanisms in lung disease
Session type:
E-Communication Session
Number:
5679
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Rohmann, J. Rupp, T. Goldmann, P. Zabel, K. Dalhoff, D. Droemann (Luebeck, Germany).
Haemophilus influenzae
(NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue. Eur Respir J 2010; 36: Suppl. 54, 5679
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
TGF-β receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung
Source: Eur Respir J 2008; 32: 285-295
Year: 2008
Amplified virus infection in a transforming growth factor-beta (TGFB) transgenic mouse model of inflammatory lung disease
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006
Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Transforming growth factor beta (TGF-β) augments rhinovirus (RV) replication in primary bronchial epithelial cells (pbecs) through modulation of the innate immune response
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006
Jun kinase regulates the expression of TGF-beta induced connective tissue growth factor in human lung fibroblast
Source: Annual Congress 2004 - Inflammation and remodelling in human lungs
Year: 2004
Differential regulation of TNF-α and TGF- β production by PAI-1 in lung cancer and endothelial cells
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
The epidermal growth factor receptor mediates allergic airway remodelling in the rat
Source: Eur Respir J 2008; 32: 1213-1223
Year: 2008
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways
Source: Eur Respir J 2010; 36: 1425-1435
Year: 2010
Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of (NF)-κB
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Influence of recombinant human vascular endothelium growth factor- (rhVEGF-) 165 on surfactant proteins (SPs) mRNA levels in emphysematous rat lungs
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003
Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids
Source: Eur Respir J 2001; 18: 115-121
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept